ACTIVE

JOHNSON & JOHNSON MEDICAL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result10,2 M €+9,0 %over 1 year
Revenue330 M €+0,1 %over 1 year
Equity80,2 M €+14,6 %over 1 year
Workforce267,5 ETP+3,2 %over 1 year

Identity

Source · BCE/KBO

JOHNSON & JOHNSON MEDICAL is a Public limited company incorporated in 1984. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 267,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0425.967.580
Incorporation
07/06/1984
Legal form
Public limited company
Registered office
Leonardo da Vincilaan 15
1831 Machelen (Brab.) · FlandreSee on map
Contributed capital
8 532 726,44 €
Latest accounts
31/12/2025
Average workforce
267,5 ETP
Joint committees (3)
  • 100
  • 200
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 14 financial years

20252024202320222021
Income statement
Revenue330 M €329,7 M €346,7 M €341,8 M €321,2 M €
EBITDA14,2 M €12,6 M €13,1 M €13,1 M €14,6 M €
Operating result12,3 M €11,1 M €10,3 M €9,1 M €8,2 M €
Net result10,2 M €9,4 M €7,7 M €6,4 M €4,7 M €
Balance sheet
Equity80,2 M €69,9 M €60,6 M €52,9 M €81,5 M €
Total assets225,6 M €199,1 M €190,6 M €132 M €191,3 M €
Cash2,1 M €1,7 M €2,1 M €1,8 M €911,6 k €
Debts134,7 M €118,2 M €117,3 M €70,8 M €102,2 M €
Other
Workforce267,5 ETP259,1 ETP264,6 ETP261,8 ETP259,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 38 ended

Active mandates

Bram Van Elsen

Managing director · since 01 février 2026 · until 16 juin 2031

Active
Fabrice Degenève

Managing director · since 27 juin 2024 · until 01 février 2026

Active
Bert Van Opdenbosch

Managing director · since 15 juin 2021 · until 15 juin 2026

Active
Katrien Lindemans

Managing director · since 15 juin 2021 · until 15 juin 2026

Active

Ended mandates

Fabrice Degenève

Managing director · since 27 juin 2024 · until 17 juin 2030

Ended
Sven Taymans

Managing director · since 01 novembre 2021 · until 01 octobre 2024

Ended
Sven Taymans

Managing director · since 01 novembre 2021 · until 21 juin 2027

Ended
Dmitry Polyakov

Managing director · since 15 juin 2021 · until 01 novembre 2024

Ended

Other companies at this address

Leonardo da Vincilaan 15 1831 Machelen (Brab.)
CompanyCBE no.
BELGIUM - LUXEMBOURG ORACLE USER GROUP● Active
0461.779.386
DePuy Synthes (Belgium)● Active
1038.037.976
GMED HEALTHCARE● Active
0822.358.674
JJSV Belgium● Active
0477.259.497
Johnson & Johnson (Belgium) Holding● Active
1038.504.467
OMRIX BIOPHARMACEUTICALS● Active
0455.883.073

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date06/07/202611/07/202509/07/202430/06/202329/06/202229/06/2021
General meeting26/06/202630/06/202527/06/202429/06/202329/06/202229/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202526/06/202606/07/2026DutchPDF
Full model31/12/202430/06/202511/07/2025DutchPDF
Full model31/12/202327/06/202409/07/2024DutchPDF
Full model31/12/202229/06/202330/06/2023DutchPDF
Full model31/12/202129/06/202229/06/2022DutchPDF
Full model31/12/202029/06/202129/06/2021DutchPDF
Full model31/12/201915/06/202018/06/2020DutchPDF
Full model31/12/201819/06/201925/06/2019DutchPDF
Full model31/12/201726/09/201826/09/2018DutchPDF
Full model31/12/201629/06/201730/06/2017DutchPDF
Full model31/12/201528/06/201628/06/2016DutchPDF
Full model31/12/201410/06/201526/06/2015DutchPDF
Full model31/12/201317/10/201420/10/2014DutchPDF
Full model31/12/201212/11/201319/11/2013DutchPDF
Full model31/12/201111/03/201315/03/2013DutchPDF
Full model31/12/201003/07/201204/07/2012DutchPDF
Full model31/12/200907/07/201105/09/2011DutchPDF
Full model31/12/200805/10/201027/10/2010DutchPDF
Full model31/12/200731/10/200831/10/2008DutchPDF
Full model31/12/200626/06/200717/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 38 ended

Active mandates

Bram Van Elsen

Managing director · since 01 février 2026 · until 16 juin 2031

Active
Fabrice Degenève

Managing director · since 27 juin 2024 · until 01 février 2026

Active
Bert Van Opdenbosch

Managing director · since 15 juin 2021 · until 15 juin 2026

Active
Katrien Lindemans

Managing director · since 15 juin 2021 · until 15 juin 2026

Active

Ended mandates

Fabrice Degenève

Managing director · since 27 juin 2024 · until 17 juin 2030

Ended
Sven Taymans

Managing director · since 01 novembre 2021 · until 01 octobre 2024

Ended
Sven Taymans

Managing director · since 01 novembre 2021 · until 21 juin 2027

Ended
Dmitry Polyakov

Managing director · since 15 juin 2021 · until 01 novembre 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/07/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/02/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates09/02/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/08/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/12/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates12/07/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/08/2023
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 01/02/2026
    nominationBram Van Elsen — bestuurder
  2. 01/02/2026
    nominationBram Van Elsen — gedelegeerd bestuurder
  3. 2025
    Annual accounts 202510,2 M €↑
  4. 29/09/2025
    nominationNico Van Tichelen — Lasthebber (bijzondere bevoegdheden inzake “Shockwave”)
  5. 12/08/2025
    nominationGrace Nicola — Lasthebber (Electrophysiology EMEA Regional Office)
  6. 12/08/2025
    nominationDmitry Polyakov — Lasthebber (Electrophysiology EMEA Regional Office)
  7. 01/07/2025
    nominationHilde Claes — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  8. 01/07/2025
    nominationInge Gabriels — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  9. 01/07/2025
    nominationLinda Diels — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  10. 01/07/2025
    nominationHeidi Moyson — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  11. 01/07/2025
    nominationEva Veraghtert — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  12. 01/07/2025
    nominationElien Couwels — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  13. 01/07/2025
    nominationSigrid Dereymaeker — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  14. 01/07/2025
    nominationFrederic Vandebroek — Lasthebber (HR aangelegenheden) / HR Betalingsgemachtigde
  15. 01/07/2025
    nominationAn De Schutter — HR Betalingsgemachtigde
  16. 01/07/2025
    nominationMarlyn Smits — HR Betalingsgemachtigde
  17. 2024
    Annual accounts 20249,4 M €↑
  18. 22/09/2024
    reconductionKevin Weggelaar — Lasthebber (Electrophysiology Technical Service)
  19. 27/06/2024
    reconductionFabrice Degenève — bestuurder
  20. 2023
    Annual accounts 20237,7 M €↑
  21. 2022
    Annual accounts 20226,4 M €↑
  22. 2021
    Annual accounts 20214,7 M €↑
  23. 2020
    Annual accounts 20202,1 M €↓
  24. 2019
    Annual accounts 20196 M €↓
  25. 2015
    Annual accounts 201512,2 M €↑
  26. 2013
    Annual accounts 20133,4 M €↓
  27. 2012
    Annual accounts 20125,2 M €↓
  28. 2011
    Annual accounts 20116,2 M €↑
  29. 2009
    Annual accounts 20093,7 M €↑
  30. 2008
    Annual accounts 20083,4 M €↓
  31. 2007
    Annual accounts 20074,8 M €
  32. 07/06/1984
    IncorporationPublic limited company